Potent carbonic anhydrase I, II, IX and XII inhibition activity of novel primary benzenesulfonamides incorporating bis-ureido moieties

AbstractA novel series of twelve aromatic bis-ureido-substituted benzenesulfonamides was synthesised by conjugation of aromatic aminobenzenesulfonamides with aromatic bis-isocyanates. The obtained bis-ureido-substituted derivatives were tested against four selected human carbonic anhydrase isoforms...

Full description

Bibliographic Details
Main Authors: Tuba Tekeli, Suleyman Akocak, Andrea Petreni, Nebih Lolak, Servet Çete, Claudiu T. Supuran
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Journal of Enzyme Inhibition and Medicinal Chemistry
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/14756366.2023.2185762
_version_ 1797400995417817088
author Tuba Tekeli
Suleyman Akocak
Andrea Petreni
Nebih Lolak
Servet Çete
Claudiu T. Supuran
author_facet Tuba Tekeli
Suleyman Akocak
Andrea Petreni
Nebih Lolak
Servet Çete
Claudiu T. Supuran
author_sort Tuba Tekeli
collection DOAJ
description AbstractA novel series of twelve aromatic bis-ureido-substituted benzenesulfonamides was synthesised by conjugation of aromatic aminobenzenesulfonamides with aromatic bis-isocyanates. The obtained bis-ureido-substituted derivatives were tested against four selected human carbonic anhydrase isoforms (hCA I, hCA II, hCA IX and hCA XII). Most of the new compounds showed an effective inhibitory profile against isoforms hCA IX and hCA XII, also having some selectivity with respect to hCA I and hCA II. The inhibition constants of these compounds against isoforms hCA IX and XII were in the range of 6.73–835 and 5.02–429 nM, respectively. Since hCA IX and hCA XII are important drug targets for anti-cancer/anti-metastatic drugs, these effective inhibitors reported here may be considered of interest for cancer related studies in which these enzymes are involved.
first_indexed 2024-03-09T02:02:31Z
format Article
id doaj.art-27d3d6164b084861b578bf702b6f3f3b
institution Directory Open Access Journal
issn 1475-6366
1475-6374
language English
last_indexed 2024-03-09T02:02:31Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Enzyme Inhibition and Medicinal Chemistry
spelling doaj.art-27d3d6164b084861b578bf702b6f3f3b2023-12-08T03:24:20ZengTaylor & Francis GroupJournal of Enzyme Inhibition and Medicinal Chemistry1475-63661475-63742023-12-0138110.1080/14756366.2023.2185762Potent carbonic anhydrase I, II, IX and XII inhibition activity of novel primary benzenesulfonamides incorporating bis-ureido moietiesTuba Tekeli0Suleyman Akocak1Andrea Petreni2Nebih Lolak3Servet Çete4Claudiu T. Supuran5Vocational School of Technical Science, Department of Chemistry and Chemical Processing Technologies, Adıyaman University, Adıyaman, TürkiyeDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Adıyaman University, Adıyaman, TürkiyeNEUROFARBA Dept., Sezione di Scienze Farmaceutiche, Università degli Studi di Firenze, Sesto Fiorentino (Florence), ItalyDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Adıyaman University, Adıyaman, TürkiyeDepartment of Chemistry, Faculty of Science, Gazi University, Ankara, TürkiyeNEUROFARBA Dept., Sezione di Scienze Farmaceutiche, Università degli Studi di Firenze, Sesto Fiorentino (Florence), ItalyAbstractA novel series of twelve aromatic bis-ureido-substituted benzenesulfonamides was synthesised by conjugation of aromatic aminobenzenesulfonamides with aromatic bis-isocyanates. The obtained bis-ureido-substituted derivatives were tested against four selected human carbonic anhydrase isoforms (hCA I, hCA II, hCA IX and hCA XII). Most of the new compounds showed an effective inhibitory profile against isoforms hCA IX and hCA XII, also having some selectivity with respect to hCA I and hCA II. The inhibition constants of these compounds against isoforms hCA IX and XII were in the range of 6.73–835 and 5.02–429 nM, respectively. Since hCA IX and hCA XII are important drug targets for anti-cancer/anti-metastatic drugs, these effective inhibitors reported here may be considered of interest for cancer related studies in which these enzymes are involved.https://www.tandfonline.com/doi/10.1080/14756366.2023.2185762Bis-ureidocarbonic anhydrasesulphonamideisoform-selective inhibitoranticancer agent
spellingShingle Tuba Tekeli
Suleyman Akocak
Andrea Petreni
Nebih Lolak
Servet Çete
Claudiu T. Supuran
Potent carbonic anhydrase I, II, IX and XII inhibition activity of novel primary benzenesulfonamides incorporating bis-ureido moieties
Journal of Enzyme Inhibition and Medicinal Chemistry
Bis-ureido
carbonic anhydrase
sulphonamide
isoform-selective inhibitor
anticancer agent
title Potent carbonic anhydrase I, II, IX and XII inhibition activity of novel primary benzenesulfonamides incorporating bis-ureido moieties
title_full Potent carbonic anhydrase I, II, IX and XII inhibition activity of novel primary benzenesulfonamides incorporating bis-ureido moieties
title_fullStr Potent carbonic anhydrase I, II, IX and XII inhibition activity of novel primary benzenesulfonamides incorporating bis-ureido moieties
title_full_unstemmed Potent carbonic anhydrase I, II, IX and XII inhibition activity of novel primary benzenesulfonamides incorporating bis-ureido moieties
title_short Potent carbonic anhydrase I, II, IX and XII inhibition activity of novel primary benzenesulfonamides incorporating bis-ureido moieties
title_sort potent carbonic anhydrase i ii ix and xii inhibition activity of novel primary benzenesulfonamides incorporating bis ureido moieties
topic Bis-ureido
carbonic anhydrase
sulphonamide
isoform-selective inhibitor
anticancer agent
url https://www.tandfonline.com/doi/10.1080/14756366.2023.2185762
work_keys_str_mv AT tubatekeli potentcarbonicanhydraseiiiixandxiiinhibitionactivityofnovelprimarybenzenesulfonamidesincorporatingbisureidomoieties
AT suleymanakocak potentcarbonicanhydraseiiiixandxiiinhibitionactivityofnovelprimarybenzenesulfonamidesincorporatingbisureidomoieties
AT andreapetreni potentcarbonicanhydraseiiiixandxiiinhibitionactivityofnovelprimarybenzenesulfonamidesincorporatingbisureidomoieties
AT nebihlolak potentcarbonicanhydraseiiiixandxiiinhibitionactivityofnovelprimarybenzenesulfonamidesincorporatingbisureidomoieties
AT servetcete potentcarbonicanhydraseiiiixandxiiinhibitionactivityofnovelprimarybenzenesulfonamidesincorporatingbisureidomoieties
AT claudiutsupuran potentcarbonicanhydraseiiiixandxiiinhibitionactivityofnovelprimarybenzenesulfonamidesincorporatingbisureidomoieties